Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

46.47
-0.5600-1.19%
Volume:1.61M
Turnover:74.81M
Market Cap:93.99B
PE:14.86
High:46.89
Open:46.77
Low:46.35
Close:47.03
52wk High:61.70
52wk Low:42.85
Shares:2.02B
Float Shares:1.94B
Volume Ratio:0.91
T/O Rate:0.08%
Dividend:1.80
Dividend Rate:3.87%
EPS(TTM):3.13
EPS(LYR):3.74
ROE:33.38%
ROA:10.01%
PB:4.03
PE(LYR):12.44

Loading ...

Movement Alert|GlaxoSmithKline PLC Falls 3.04% in Regular Trading, Trading at $49.525

Market Focus
·
Sep 18

UBS Remains a Hold on GlaxoSmithKline (GSK)

TIPRANKS
·
Sep 18

GSK Climbs Thursday, Outperforms Market

Dow Jones
·
Sep 18

Positive Report for GlaxoSmithKline (GSK) from Berenberg Bank

TIPRANKS
·
Sep 16

Sector Update: Healthcare

MT Newswires Live
·
Sep 16

Is the Shingles Vaccine the Secret to Living Longer and Delaying Dementia? Here's What the Science Says.

Dow Jones
·
Sep 15

GSK upgraded to Buy from Hold at Berenberg

TIPRANKS
·
Sep 15

GSK Doubles Down On Oncology: Buys Global Rights To Chimagen's Trispecific TCE For Up To $750 Million

Options & Short Sell
·
Sep 15

GlaxoSmithKline (GSK) Gets a Hold from RBC Capital

TIPRANKS
·
Sep 15

GSK Rises Monday, Outperforms Market

Dow Jones
·
Sep 15

European Equities Traded in the US as American Depositary Receipts Drop in Monday Trading

MT Newswires Live
·
Sep 14

Roche, GSK's Lung-Cancer Drug Candidates Show Promise in China

Dow Jones
·
Sep 14

Movement Alert|GlaxoSmithKline PLC Rises 4.07% in Regular Trading, Lung Cancer Drug Jideytro Achieves 94% Response Rate in First-Line Trial

Market Focus
·
Sep 14

Sector Update: Healthcare Stocks Rise Premarket Monday

MT Newswires Live
·
Sep 14

【US Pre-Market】US Stock Futures Fall as AI Giants Call to Slow Model Development; AI Supply Chain Tumbles, Led by Memory and Optical Sectors

TradingKey
·
Sep 14

Movement Alert|GlaxoSmithKline PLC Rises 3.32% in Pre-Market Trading, Lung Cancer Drug Jideytro Achieves 94% Response Rate in First-Line Trial

Market Focus
·
Sep 14

J.P. Morgan Reaffirms Their Sell Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Sep 14

GSK's Potential Small-Cell Lung Cancer Drug Meets Primary Endpoint in Late-Stage Trial

MT Newswires Live
·
Sep 14

Big Pharma is Pouring Billions into China's Biotechs

Dow Jones
·
Sep 14

GSK Says New Lung-Cancer Drug Shows Benefits at Earlier Stage of Treatment

Dow Jones
·
Sep 14